Maravai Lifesciences Holdings (MRVI) Change in Receivables (2020 - 2026)

Maravai Lifesciences Holdings' Change in Receivables history runs 7 years deep, the most recent figure standing at $7.9 million for Q1 2026.

• In Q1 2026, Change in Receivables rose 177.89% year-over-year to $7.9 million; the TTM figure through Mar 2026 stood at $5.3 million (up 179.23% YoY), while the FY2025 annual figure was -$12.8 million, up 10.75% from the prior year.
• Change in Receivables was $7.9 million for Q1 2026 at Maravai Lifesciences Holdings, up from $3.0 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $25.8 million in Q4 2022 to a low of -$82.4 million in Q1 2023.
• Historically, Change in Receivables has averaged -$4.8 million across 5 years, with a median of -$1.9 million in 2024.
• The sharpest annual moves came in 2023 and 2026: Change in Receivables tumbled 6674.78% in 2023, then jumped 177.89% in 2026.
• A 5-year view of Change in Receivables shows it stood at $25.8 million in 2022, then plunged by 65.92% to $8.8 million in 2023, then jumped by 30.11% to $11.4 million in 2024, then sank by 74.09% to $3.0 million in 2025, then surged by 167.27% to $7.9 million in 2026.
• The last three Change in Receivables figures came in at $7.9 million (Q1 2026), $3.0 million (Q4 2025), and -$5.1 million (Q3 2025), per Business Quant data.